Rachel Suzanne Liodakis, MD
Family Practice · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 7
- Since medical school
- 6 years
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 2020
Offices
7 locations · University of California San Francisco · UCSF Medical Group Business Services
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liodakis’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A185896 · Current
Licensed to practise in California · since 2023 · expires 2027-06-30 · Rutgers, Robert Wood Johnson Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$64
Medicare paid this office $64 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 71 · 85 and older 0% · Health risk score 1.07. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
The office billed $137, Medicare allowed $68 and paid $64; for 14 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$249,551 in 2024
Medicaid paid $249,551 for 2,999 billed services this clinician did in 2024, up to 171 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,114 | $247,032 |
| Short return visit | 1,486 | $1,613 |
| Short return visit (20+ min) | 374 | $907 |
| Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 25 | $0 |
| 2024 | 2,999 | 4 | 171 | $249,551 |
| 2023 | 1,553 | 8 | 132 | $125,152 |
| 2022 | 57 | 2 | 22 | $10,667 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 552 | $122,818 |
| Short return visit (20+ min) | 439 | $823 |
| Return visit (30+ min) | 151 | $699 |
| Short return visit | 231 | $384 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 51 | $202 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 58 | $122 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 53 | $99 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 18 | $6 |
2022
| Clinic visit/encounter, all-inclusive | 44 | $10,667 |
| Short return visit (20+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$204,948
Pharmacies billed $204,948 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (22 of 1,986) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,696 generic and 269 brand-name prescriptions · $204,948 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 48 | $62,906 | $1,311 |
| Trulicity | 20 | $29,071 | $1,454 |
| Eliquis | 12 | $18,963 | $1,580 |
| Buprenorphine-Naloxone | 11 | $1,639 | $149 |
| Albuterol Sulfate Hfa | 41 | $1,495 | $36 |
See all 35 drugs
| Jardiance | 48 | $62,906 | $1,311 |
| Trulicity | 20 | $29,071 | $1,454 |
| Eliquis | 12 | $18,963 | $1,580 |
| Buprenorphine-Naloxone | 11 | $1,639 | $149 |
| Albuterol Sulfate Hfa | 41 | $1,495 | $36 |
| Atorvastatin | 184 | $1,081 | $6 |
| Metoprolol | 59 | $895 | $15 |
| Levothyroxine | 75 | $792 | $11 |
| Ultra-Fine Mini Pen Needle | 13 | $758 | $58 |
| Metformin | 102 | $704 | $7 |
| Gabapentin | 48 | $683 | $14 |
| Omeprazole | 69 | $642 | $9 |
| Fluticasone Propionate | 81 | $598 | $7 |
| Amlodipine Besylate | 120 | $596 | $5 |
| Glipizide | 30 | $419 | $14 |
| Lisinopril | 67 | $389 | $6 |
| Diclofenac | 18 | $388 | $22 |
| Famotidine | 32 | $382 | $12 |
| Pravastatin | 31 | $378 | $12 |
| Losartan | 77 | $349 | $5 |
| Trazodone | 35 | $316 | $9 |
| Rosuvastatin | 25 | $259 | $10 |
| Pantoprazole | 21 | $246 | $12 |
| Enalapril Maleate | 13 | $215 | $17 |
| Tamsulosin | 30 | $212 | $7 |
| Benazepril | 19 | $192 | $10 |
| Baclofen | 20 | $182 | $9 |
| Furosemide | 26 | $173 | $7 |
| Clopidogrel | 14 | $150 | $11 |
| Metoprolol | 24 | $135 | $6 |
| Simvastatin | 24 | $110 | $5 |
| Ibuprofen | 22 | $76 | $3 |
| Alendronate | 17 | $72 | $4 |
| Hydrochlorothiazide | 36 | $70 | $2 |
| Sertraline | 12 | $32 | $3 |
Year by year
| 2024 | 1,986 | 233 | 1% (22) | 14% | $204,948 |
| 2023 | 692 | 180 | 3% (17) | None | $78,463 |
| 2022 | 307 | 68 | None | None | $60,795 |
| 2021 | 57 | 17 | 0% (0) | None | $8,721 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Jardiance | 20 | $21,042 | $1,052 |
| Atorvastatin | 53 | $963 | $18 |
| Albuterol Sulfate Hfa | 19 | $815 | $43 |
| Gabapentin | 14 | $742 | $53 |
| Amlodipine Besylate | 37 | $598 | $16 |
| Metformin | 31 | $540 | $17 |
| Omeprazole | 27 | $490 | $18 |
| Fluticasone Propionate | 37 | $447 | $12 |
| Diclofenac | 13 | $356 | $27 |
| Trazodone | 14 | $313 | $22 |
| Losartan | 30 | $309 | $10 |
| Lisinopril | 16 | $268 | $17 |
| Pantoprazole | 14 | $224 | $16 |
| Levothyroxine | 11 | $190 | $17 |
2022: 7 drugs
| Jardiance | 14 | $19,292 | $1,378 |
| Ozempic | 15 | $16,035 | $1,069 |
| Metformin | 16 | $146 | $9 |
| Omeprazole | 17 | $139 | $8 |
| Atorvastatin | 14 | $138 | $10 |
| Fluticasone Propionate | 15 | $113 | $8 |
| Amlodipine Besylate | 13 | $107 | $8 |
Professional record
- NPI
- 1164042768
- Licence
- CA A185896California A185896: Current · expires 2027-06-30
- Trained
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 2020 · 6 years ago
- Group
- University of California San Francisco · UCSF Medical Group Business Services
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr Ste 250, San Jose, CA, 95128
- NPI first listed
- 2020-04-23
- NPI last updated
- 2025-08-07
- NPI record certified
- 2025-08-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1333 Meridian Ave, San Jose, CA, 95125